Directs the commissioner of health to conduct a sickle cell disparity study

S 6178 requires New York's health commissioner to study whether people with sickle cell disease face worse access to treatment compared to those with other chronic conditions like lupus, cancer, diabetes, or heart disease. The study must examine differences in both the availability and affordability of care for sickle cell patients versus others. Results must be published online within 18 months of the law's effective date, and the bill expires two years after enactment. This legislation directly affects sickle cell disease patients by mandating an analysis of healthcare access disparities.